Electra Therapeutics, Inc. - 10-Q Filing

Electra Therapeutics, Inc. reports Q3 financial results featuring Series C Preferred Stock issuance and ongoing R&D expenditure.

SEC EDGAR ·

Tickers: $ETRA

Read the full article at SEC EDGAR

More Regulatory news